EssilorLuxottica announces the launch of a share buyback program

EssilorLuxottica announces the launch of a share buyback program

Paris, France (August 28, 2026 – 8:00am) – EssilorLuxottica announces the launch of a share buyback program, reflecting the Group’s confidence in its value creation and long-term prospects.

With a view to implementing this share buyback program, EssilorLuxottica has granted a mandate to an investment services provider to purchase up to 5,000,000 EssilorLuxottica shares, depending on market conditions, starting today, August 28, 2026.

EssilorLuxottica launches this share buyback program in accordance with the 19th resolution approved by the Annual General Meeting of April 28, 2026¹.

Footnote

Contacts

Giorgio Iannella
Head of Investor Relations
E ir@essilorluxottica.com

Marco Catalani
Head of Corporate Communications
E media@essilorluxottica.com

About EssilorLuxottica

EssilorLuxottica is a global leader in the design, manufacture and distribution of advanced vision care products, eyewear and med-tech solutions. The Group is home to the most innovative lens technologies, including Varilux, Stellest and Transitions, iconic brands such as Ray-Ban, Oakley and Supreme, top-selling smart eyewear products including Ray-Ban Meta, Oakley Meta Vanguard and Nuance Audio, the most desired luxury licensed brands and world-class retailers including Sunglass Hut, LensCrafters, Vision Express and Apollo. With 210,000 employees across 150 countries, 600 operations facilities, serving 300,000 eye care professionals and operating approximately 20,000 stores, the Group generated consolidated revenue of Euro 28.5 billion in 2025. EssilorLuxottica trades on the Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices. Codes and symbols: ISIN: FR0000121667; Reuters: ESLX.PA; Bloomberg: EL:FP.
www.essilorluxottica.com

Notes

1. Description of the EssilorLuxottica’s share buyback program is available in the 2025 Universal Registration Documents published on EssilorLuxottica’s website under section “Regulatory Information”.